Hikma Adds Remsima SC To Celltrion MENA Collaboration

Subcutaneous Version Of Infliximab Joins Three Other Celltrion Biosimilars

MENA
Remsima SC joins Hikma’s MENA alliance with Celltrion • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business